Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Title:
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Author:
Kolstad, Arne Illidge, Tim Bolstad, Nils Spetalen, Signe Madsbu, Ulf Stokke, Caroline Blakkisrud, Johan Løndalen, Ayca O'Rourke, Noelle Beasley, Matthew Jurczak, Wojciech Fagerli, Unn-Merete Kaščák, Michal Bayne, Mike Obr, Aleš Dahle, Jostein Rojkjaer, Lisa Pascal, Veronique Holte, Harald